Human Tissue (Authorisation) (Scotland) Bill: BRIA
Business and Regulatory Impact Assessment (BRIA) exploring the costs and benefits associated with the move to a soft opt out system of organ and tissue donation.
5.0 Scottish Firms Impact Test
It is not envisaged that the legislation will result in any impacts on businesses.
5.1 Competition Assessment
It is not envisaged that the legislation will result in any impacts on businesses and therefore it is not envisaged that there will be any impacts on competition.
5.2 Test run of business forms
It is not envisaged that the legislation will result in any new business forms. The legislation will result in new forms for organisations working directly in organ donation, namely NHSBT and SNBTS. These will be developed jointly by the relevant organisations.
Contact
There is a problem
Thanks for your feedback